Cargando…
Surface plasmon resonance unveils important pitfalls of enzyme-linked immunoassay for the detection of anti-infliximab antibodies in patients’ sera
Measurements of serum concentrations of therapeutic antibodies and anti-drug antibodies (ADA) can support clinical decisions for the management of non-responders, optimizing the therapy. In the present study we compared the results obtained by classical ELISA and a recently proposed surface plasmon...
Autores principales: | Beeg, Marten, Burti, Cesare, Allocati, Eleonora, Ciafardini, Clorinda, Banzi, Rita, Nobili, Alessandro, Caprioli, Flavio, Garattini, Silvio, Gobbi, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298394/ https://www.ncbi.nlm.nih.gov/pubmed/34294782 http://dx.doi.org/10.1038/s41598-021-94431-x |
Ejemplares similares
-
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies
por: Beeg, Marten, et al.
Publicado: (2019) -
Switching Among Biosimilars: A Review of Clinical Evidence
por: Allocati, Eleonora, et al.
Publicado: (2022) -
A portable optical-fibre-based surface plasmon resonance biosensor for the detection of therapeutic antibodies in human serum
por: Zeni, Luigi, et al.
Publicado: (2020) -
Pharmaceutical Strategy for Europe: Reflections on Public Health-Driven Drug Development, Regulation, and Policies
por: Garattini, Silvio, et al.
Publicado: (2021) -
B cell epitopes on infliximab identified by oligopeptide microarray with unprocessed patient sera
por: Homann, Arne, et al.
Publicado: (2015)